Tango Therapeutics, Inc. (TNGX) Form 10-Q Quarterly Reports
Tango Therapeutics, Inc. (TNGX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TNGX
CIK: 1819133
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerKaren Pfeil
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414500 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | 4 | 0001193125-26-401327 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009747 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 | 0001193125-26-381853 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001916761-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352271 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000886982-26-000510 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005265 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000908834-26-000425 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004954 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344997 | View SEC Doc Filr Page |
| 424B5 | 2026-08-11 | — | 424B5 | 0001193125-26-344989 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343434 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343424 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-07 | 2026-07-31 | 8-K/A | 0001193125-26-339070 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-07-31 | 8-K | 0001193125-26-338480 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335002 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007562 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-295124 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | 4 | 0001193125-26-279871 | View SEC Doc Filr Page |
| 3 | 2026-06-23 | 2026-06-19 | 3 | 0001193125-26-279866 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-19 | 8-K | 0001193125-26-279788 | View SEC Doc Filr Page |
| 144 | 2026-06-17 | — | 144 Filing | 0001894038-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-06-11 | — | 144 Filing | 0001950047-26-005968 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-09 | 8-K | 0001193125-26-266078 | View SEC Doc Filr Page |